Fictional science medicine is here, but orderers will be late to read

The financing of its high cost condition the implantation of advances that are produced in techniques and technology, although also in order to resolve ethical and formative aspects

16 December 2020. 16:38

La futuro medicine, it’s been a long time since anyone knew science fiction, and it’s a reality on campos like the Cellular and genetic therapy or in the implementation of programs that allow to control millions of data. But because of the enormous power of these products, the most sophisticated technologies “will never replace the professional. We are not looking for a future future of bidders ”.

This is a graphic presentation by José Manuel Jerez, Chair of Languages ​​and Informatics Systems of the University of Málaga, which was one of the points in the III Jornada ‘Anticipating the Medicine of the Future’, organized by the Foundation Roche for Analyzing ya es presente. Some of the most spectacular advances that have their reality, no matter what, they are all about important things, especially the financing of its elevated cost, there is a debate over ethical issues and the need for a mayoral training of professionals to boost clinical application.

The point of departure of the journada fueron los tres nuesos Informes ‘Anticipando’ impulsados ​​par el Observatorio de Tendencias en la Medicina del Futuro, dedicados a las advanced therapies (cellular and genetic), al exposure ya los Ethical and Legal Rights of the Kunsmatige Intelligence (IA) and salud. In this last month, José Manuel Jerez said that, although it was not until the beginning of the season that a robot with a recovery was established in medicine, it was decided that the most spectacular results in relation to the IA would be in the process of images, up to the point where an algorithm can detect with a mayor that a professional team determines tumor types. The medicine of the future, in its juice, “will be a problem of engineering in addition to medicine”.

New professional profiles

Coincidentally with the appointment, Guillén, President of the Spanish Association of Human Genetics (AEGH), stated that “the professional will always be the key”. There are, however, fundamental issues for which these issues are: “very important” is a major of the training and it is “critical” that new professional profiles be incorporated, “we need to understand the processes”.

The coordinator of the information on the ethical and legal rules that artificial intelligence has planted is Carlos Romeo, coordinator of the Research Group of the Cathedral of the Peace and Human Genome of the University of Pais Vasco, for which one of the principal principles in salute is the the re-identification of anonymous or anonymous personal data. This is the sum of his concern for the autonomy of the medical front in the proposals that plant an IA and the risk of depersonalization of the relationship between professional and patient.

In this case, the need to generate trust in these new regulations regarding the reality of transparency and adequate control, as long as the union re-indicates the mayor’s possible date and increase its integration, much needed to record a full interconnection at the level of the National Health System. The IA, for the time being, is used for the infinity of applications, as the search for new options for medicines is in use, although, based on the fact that no one has been able to contact human, his main support can be that the professionals ganen tiempo.

Outside of the jornada months of the ‘Advanced Therapies: Cellular Therapy and Genetic Therapy’, one of the techniques dedicated to adjectives such as “Spectacular”, “Incredible”, “Extraordinary”, “Alucinating” or “Impressive”. The context of the situation is the moderator, Ángel Carracedo, director of the Public Health Fund of Genome Medicine Genome, which concluded that in 2027 there will be more than 1,000 treatments to treat rare diseases or, in this same year, 10% of the guest in medicine ‘n estar ligado a estas pathologías.

Management of the expectant

The participants coincide with the spectacularity of a therapies that support a paradigm shift, up to the point where the curative treatment of very advanced neoplasms is allowed. This is a huge success, explains Felipe Prósper, Director of the Cellular Therapy Area of ​​the Clinic of the University of Navarre, and it is the management of the expectant, and these techniques “do not cure all the diseases of patients who have tener toxicidades y van a seguir recayendo ”.

“It’s revolutionary, but it’s transmitting a calm calm, even if it’s very honorable because the expectant is brutal. Associated with this, one of its major problems is that we are dealing with “a cost for the system that we are probably prepared to abort”, which can provide payment mechanisms that will undermine the fundamental pillar of equity. “Our system does not have a problem, it does not tend to be a problem”.

In the same month, it is also known that the ethical aspects in this camp will be resolved with the introduction of the multi-potentially induced cells, which are well part of the moral dilemma planted initially by some professionals. Superada is this situation, otherwise the retentions are the transfer of the knowledge of the investigators to the clinical practice, which is the sum of the re-indication of a genomics or genetics assignment in the Medical Studies.

The last month is central to the exposure, the conjunction of external and ambient factors to which a person has been exposed since the beginning of death. In general terms, it coincides with the appointment with anterior, like the need to increase funding and training, in addition to the importance of introducing new professional profiles. It is united by the networks, it incorporates all these advances to the Primary Attenuation and it can carry out studies that include dates of any dates of subjects.